BG25995A3 - Метод за получаване на хексахидро-дибензо(в,d)пиран-9-они - Google Patents

Метод за получаване на хексахидро-дибензо(в,d)пиран-9-они

Info

Publication number
BG25995A3
BG25995A3 BG028126A BG2812674A BG25995A3 BG 25995 A3 BG25995 A3 BG 25995A3 BG 028126 A BG028126 A BG 028126A BG 2812674 A BG2812674 A BG 2812674A BG 25995 A3 BG25995 A3 BG 25995A3
Authority
BG
Bulgaria
Prior art keywords
dibenzo
hexahydro
pyran
ones
preparation
Prior art date
Application number
BG028126A
Other languages
Bulgarian (bg)
English (en)
Inventor
Robert Archer
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG25995A3 publication Critical patent/BG25995A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
BG028126A 1973-11-05 1974-11-05 Метод за получаване на хексахидро-дибензо(в,d)пиран-9-они BG25995A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US413009A US3928598A (en) 1973-11-05 1973-11-05 Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug

Publications (1)

Publication Number Publication Date
BG25995A3 true BG25995A3 (bg) 1979-01-12

Family

ID=23635412

Family Applications (1)

Application Number Title Priority Date Filing Date
BG028126A BG25995A3 (bg) 1973-11-05 1974-11-05 Метод за получаване на хексахидро-дибензо(в,d)пиран-9-они

Country Status (25)

Country Link
US (1) US3928598A (zh)
JP (1) JPS6033834B2 (zh)
AR (1) AR206409A1 (zh)
AT (1) AT337178B (zh)
BE (1) BE821719A (zh)
BG (1) BG25995A3 (zh)
CA (1) CA1029383A (zh)
CH (1) CH611290A5 (zh)
CS (1) CS193506B2 (zh)
DD (1) DD116229A5 (zh)
DE (1) DE2451932C2 (zh)
DK (1) DK136718B (zh)
ES (1) ES431675A1 (zh)
FR (1) FR2249663B1 (zh)
GB (1) GB1487636A (zh)
HU (1) HU169192B (zh)
IE (1) IE40025B1 (zh)
IL (1) IL45662A (zh)
NL (1) NL180979C (zh)
PH (1) PH10476A (zh)
PL (2) PL100502B1 (zh)
SE (1) SE415761B (zh)
SU (1) SU515457A3 (zh)
YU (1) YU36946B (zh)
ZA (1) ZA745794B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4102902A (en) * 1976-11-10 1978-07-25 Eli Lilly And Company Stereoselective preparation of hexahydro dibenzopyranones and intermediates therefor
US4351833A (en) * 1980-07-28 1982-09-28 Pfizer Inc. 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US5498419A (en) * 1994-06-03 1996-03-12 Pars; Harry G. Fumarate salt of 4-(diethyl-3-(1-methyloctyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, 4-(diethyl-amino) butyric
WO1999057106A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
DE60033834T2 (de) 1999-10-18 2007-11-15 The University Of Connecticut, Farmington Für periphäre cannabinoid-rezeptoren selektive liganden
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US6900236B1 (en) * 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
WO2002026728A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
WO2002058636A2 (en) * 2001-01-26 2002-08-01 University Of Connecticut Novel cannabimimetic ligands
US7173027B2 (en) 2001-01-29 2007-02-06 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
US7057076B2 (en) * 2001-07-13 2006-06-06 University Of Connecticut Bicyclic and tricyclic cannabinoids
EP1448557A4 (en) * 2001-10-26 2005-02-02 Univ Connecticut HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
AU2003265663A1 (en) 2002-08-23 2004-03-11 University Of Connecticut Keto cannabinoids with therapeutic indications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans

Also Published As

Publication number Publication date
IL45662A (en) 1978-03-10
JPS5082073A (zh) 1975-07-03
YU36946B (en) 1984-08-31
DK136718B (da) 1977-11-14
AT337178B (de) 1977-06-10
CH611290A5 (zh) 1979-05-31
AU7329074A (en) 1976-03-18
PH10476A (en) 1977-05-11
NL7414437A (nl) 1975-05-07
NL180979B (nl) 1987-01-02
GB1487636A (en) 1977-10-05
IL45662A0 (en) 1974-11-29
CS193506B2 (en) 1979-10-31
DE2451932C2 (de) 1983-09-29
SE415761B (sv) 1980-10-27
US3928598A (en) 1975-12-23
NL180979C (nl) 1987-06-01
PL94965B1 (zh) 1977-09-30
JPS6033834B2 (ja) 1985-08-05
DK136718C (zh) 1978-04-24
FR2249663A1 (zh) 1975-05-30
SE7413832L (zh) 1975-05-06
YU261974A (en) 1982-06-18
HU169192B (zh) 1976-10-28
BE821719A (fr) 1975-04-30
ZA745794B (en) 1976-04-28
DD116229A5 (zh) 1975-11-12
CA1029383A (en) 1978-04-11
SU515457A3 (ru) 1976-05-25
ATA886274A (de) 1976-10-15
DE2451932A1 (de) 1975-05-07
ES431675A1 (es) 1977-04-16
PL100502B1 (pl) 1978-10-31
IE40025L (en) 1975-05-05
FR2249663B1 (zh) 1978-03-24
AR206409A1 (es) 1976-07-23
IE40025B1 (en) 1979-02-28
DK573174A (zh) 1975-07-07

Similar Documents

Publication Publication Date Title
BG25995A3 (bg) Метод за получаване на хексахидро-дибензо(в,d)пиран-9-они
DK134345B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater.
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
BG21394A3 (bg) Метод за получаване на 1-арилокси-2-хидрокси-3- алкинил-аминопропани
BG27079A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4-оксипиперидин
BG27080A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
DK134031B (da) Fremgangsmåde til fremstilling af et endo-beta-glucanase-præparat.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
NO740320L (no) Fremgangsmåte for fremstilling 6-deoksyoksytetracyklin.
BG27081A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
BG25997A3 (bg) Метод за получаване на 7- ациламидо- 7- метоксицефалоспорини
IT1020641B (it) Procedimento per la preparazione permentativa di l. istidina
BG22404A3 (bg) Метод за получаване на а-аминоацил-3-халоцефалоспорини
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
DK139716B (da) Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater.
BG20583A3 (bg) Метод за получаване на 2,6-диамино-дихидропиридини
BG22387A3 (bg) Метод за получаване на n,n-диалилдихлорацетамид
DK136619B (da) Fremgangsmåde til fremstilling af dihydrokanadensolid.
BG23006A3 (bg) Метод за получаване на имидазо-(1,2-а)-сим.-триазини
DK137928B (da) Fremgangsmåde til fremstilling af 5alfa-hydroxygona-9,11-diener.
IT1007377B (it) Metodo per la preparazione di polialchenameri
DK136603B (da) Fremgangsmåde til fremstilling af 1alfa-hydroxycholecalciferol.
DK134240B (da) Fremgangsmåde til fremstilling af bicyclomycin.
DK135809B (da) Analogifremgangsmåde til fremstilling af 4-oxo-benzocycloheptathiophenderivater.